Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Ruth McDermott

Ruth McDermott

Platform Manager, Regenerative Medicine

Ruth joined Sartorius’ Regenerative Medicine Applications Unit in 2017. Ruth’s strategic marketing responsibilities include helping position Sartorius as a solution provider for cell and gene therapy applications.
Before joining Sartorius, Ruth has held business development roles at Agilent Technologies, GE Healthcare, Life Technologies and Novozymes Biopharma. Ruth’s scientific knowledge has been built on a background of research in cell bioprocessing, stem cells and gene therapy. Ruth holds a PhD in Cell Biology and an MBA.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd